Home Page ::: Clinical Anti-Inflammatory & Anti-Allergy Drugs

ISSN: 2212-7046 (Online)
ISSN: 2212-7038 (Print)

Volume 1, 2 Issues, 2014

Clinical Anti-Inflammatory & Anti-Allergy Drugs

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online


Giovanni Passalacqua

Allergy & Respiratory Diseases
Department of Internal Medicine
University of Genova

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Clinical Anti-Inflammatory & Anti-Allergy Drugs


Volume 1


Number 1

Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

; Pp: 2 - 10

Lawren C. Wu, Joseph R. Arron, Jeffrey M. Harris, John G. Matthews and Karin Rosen

DOI: 10.2174/2212703801999131206110837
Abstract Download Reprints Eprints Rights & Permissions


Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody

; Pp: 24 - 31

Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu

DOI: 10.2174/22127038114019990003
Abstract Download Reprints Eprints Rights & Permissions


Activin-A: A New Piece in the Puzzle of Tolerance in Asthma

; Pp: 45 - 56

Sofia Tousa, Maria Semitekolou, Ioannis Morianos, Aikaterini I Trochoutsou and Georgina Xanthou

DOI: 10.2174/2212703801666140221004020
Abstract Download Reprints Eprints Rights & Permissions


Hydrogen Sulfide: A New Tool to Design and Develop Drugs

; Pp: 57 - 66

Nethaji Muniraj, Abel Damien Ang, Alireza Badiei, Jack Rivers-Auty and Madhav Bhatia

DOI: 10.2174/2212703801666140311005131
Abstract Download Reprints Eprints Rights & Permissions



Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science